Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration.
Meyer
C H
CH
Mennel
S
S
Schmidt
J C
JC
Kroll
P
P
D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000188:drug therapy*; D006801:Humans; D007267:Injections / Q000009:adverse effects; D008268:Macular Degeneration / Q000150:complications*; D008297:Male; D008875:Middle Aged; D010857:Pigment Epithelium of Eye / Q000293:injuries*
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab